| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $25.7M | +85.2% |
| Cost of Revenue | $17.4M | +85.6% |
| Gross Profit | $8.2M | +84.5% |
| R&D Expense | $4.6M | +11.5% |
| SG&A Expense | $5.2M | -48.0% |
| Operating Income | -$29.3M | -24.3% |
| Pre-tax Income | -$28.9M | -30.5% |
| Income Tax | $43K | +458.3% |
| Net Income | -$28.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.7M | -76.0% |
| Accounts Receivable | $6.0M | +92.4% |
| Inventory | $6.7M | +18.9% |
| Current Assets | $21.3M | -45.7% |
| Total Assets | $30.5M | -51.8% |
| Current Liabilities | $10.2M | -13.3% |
| Total Liabilities | $11.6M | -30.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.7M | -5.1% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $0 | +100.0% |
| Free Cash Flow | -$21.7M | -4.7% |
| -30.8% |
| EPS (Basic) | -$3.33 | -800.0% |
| EPS (Diluted) | -$3.33 | -800.0% |
| Stockholders' Equity |
| $18.8M |
| -59.5% |